Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women

Cytokine

Volumn 30, Issue 1, 2005, Pages 1-6

  Ho, Gloria Y F ^a   Xue, Xiao Nan ^a   Burk, Robert D ^a   Kaplan, Robert C ^a   Cornell, Elaine ^b   Cushman, Mary ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Interleukin 6; Soluble interleukin 6 receptor; Tumor necrosis factor alpha; Variability

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 6; RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 15244347218     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2004.08.008     Document Type: Article

References (41)

1. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
2. M. Yuan, N. Konstantopoulos, J. Lee, L. Hansen, Z.-W. Li, M. Karin, and S.E. Shoelson Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ Science 293 2001 1673 1677
3. E. Shacter, and S.A. Weitzman Chronic inflammation and cancer Oncology (Huntingt) 16 217-226 2002 229
4. J. Danesh, R. Collins, P. Appleby, and R. Peto Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. Meta-analyses of prospective studies J Am Med Assoc 279 1998 1477 1482
5. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
6. A.D. Pradhan, J.E. Manson, J.E. Rossouw, D.S. Siscovick, C.P. Mouton, and N. Rifai Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis from the Women's Health Initiative observational study J Am Med Assoc 288 2002 980 987
7. M. Cesari, B.W. Penninx, A.B. Newman, S.B. Kritchevsky, B.J. Nicklas, and K. Sutton-Tyrrell Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study) Am J Cardiol 92 2003 522 528
8. J.D. Curb, R.D. Abbott, B.L. Rodriguez, P. Sakkinen, J.S. Popper, and K. Yano C-reactive protein and the future risk of thromboembolic stroke in healthy men Circulation 107 2003 2016 2020
9. P.M. Ridker, N. Rifai, M.J. Stampfer, and C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772
10. T.B. Harris, L. Ferrucci, R.P. Tracy, M.C. Corti, S. Wacholder, and W Ettinger Jr. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly Am J Med 106 1999 506 512
11. G. Luc, J.M. Bard, I. Juhan-Vague, J. Ferrieres, A. Evans, and P. Amouyel C-Reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study Arterioscler Thromb Vasc Biol 23 2003 1255 1261
12. T.P. Erlinger, E.A. Platz, N. Rifai, and K.J. Helzlsouer C-Reactive protein and the risk of incident colorectal cancer JAMA 291 2004 585 590
13. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
14. R.J. Moore, D.M. Owens, G. Stamp, C. Arnott, F. Burke, and N. East Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis Nat Med 5 1999 828 831
15. S. Ariasnegrete, K. Keller, and K. Chadee Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages Biochem Biophys Res Commun 208 1995 582 589
16. S.G. Harris, J. Padilla, L. Koumas, D. Ray, and R.P. Phipps Prostaglandins as modulators of immunity Trends Immunol 23 2002 144 150
17. S.M. Prescott, and F.A. Fitzpatrick Cyclooxygenase-2 and carcinogenesis Biochim Biophys Acta 1470 2000 M69 M78
18. M. Jaiswal, N.F. LaRusso, L.J. Burgart, and G.J. Gores Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 60 2000 184 190
19. K.J. O'Byrne, A.G. Dalgleish, M.J. Browning, W.P. Steward, and A.L. Harris The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease Eur J Cancer 36 2000 151 169
20. S.A. Jones, S. Horiuchi, N. Topley, N. Yamamoto, and G.M. Fuller The soluble interleukin 6 receptor: mechanisms of production and implications in disease FASEB J 15 2001 43 58
21. P.M. Ridker, N. Rifai, M.A. Pfeffer, F. Sacks, and E. Braunwald Long-term effects of pravastatin on plasma concentration of C-reactive protein Circulation 100 1999 230 235
22. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, and A. Rumley C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
23. G.Y.F. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 1998 423 428
24. B. Rosner Fundamentals of biostatistics 2000 Pacific Grove Duxbury
25. F. Cava, C. Gonzalez, M.J. Pascual, J.A. Navajo, and J.M. Gonzalez-Buitrago Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals Cytokine 12 2000 1423 1425
26. C. Gonzalez, F. Cava, A. Ayllon, P. Guevara, J.A. Navajo, and J.M. Gonzalez-Buitrago Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals Clin Chem Lab Med 39 2001 836 841
27. B. Dugue, and E. Leppanen Short-term variability in the concentration of serum interleukin-6 and its soluble receptor in subjectively healthy persons Clin Chem Lab Med 36 1998 323 325
28. N. Aziz, P. Nishanian, J.M.G. Taylor, R.T. Mitsuyasu, J.M. Jacobson, and B.J. Dezube Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection J Infect Dis 179 1999 843 848
29. H.V. Thomas, T.J. Key, D.S. Allen, J.W. Moore, M. Dowsett, and I.S. Fentiman A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey Br J Cancer 76 1997 401 405
30. S.E. Hankinson, J.E. Manson, D. Spiegelman, W.C. Willett, C. Longcope, and F.E. Speizer Reproducibility of plasma hormone levels in postmenopausal women over a 2-3 year period Cancer Epidemiol Biomarkers Prev 4 1995 649 654
31. J.A. Cauley, J.P. Gutai, L.H. Kuller, and J.G. Powell Reliability and interrelations among serum sex hormones in postmenopausal women Am J Epidemiol 133 1991 50 57
32. C.K. Sites, M.J. Toth, M. Cushman, G.D. L'Hommedieu, A. Tchernof, and R.P. Tracy Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal Fertil Steril 77 2002 128 135
33. J.-M. Fernandez-Real, M. Vayreda, C. Richart, C. Gutierrez, M. Broch, and J. Vendrell Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women J Clin Endocrinol Metab 86 2001 1154 1159
34. D. Geffken, M. Cushman, G. Burke, J. Polak, P. Sakkinen, and R. Tracy Association between physical activity and markers of inflammation in a healthy elderly population Am J Epidemiol 153 2001 242 250
35. E.A. Bermudez, N. Rifai, J. Buring, J.E. Manson, and P.M. Ridker Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women Arterioscler Thromb Vasc Biol 22 2002 1668 1673
36. T. Skoog, W. Dichtl, S. Boquist, C. Skoglund-Andersson, F. Karpe, and R. Tang Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men Eur Heart J 23 2002 376 383
37. L. Undar, C. Ertugrul, H. Altunbas, and S. Akca Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6 Thromb Haemost 81 1999 571 575
38. K.M. Chiu, C.D. Arnaud, J. Ju, D. Mayes, P. Bacchetti, and S. Weitz Correlation of estradiol, parathyroid hormone, interleukin-6, and soluble interleukin-6 receptor during the normal menstrual cycle Bone 26 2000 79 85
39. G. Kenis, C. Teunissen, R. DeJongh, E. Bosmans, H. Steinbusch, and M. Maes Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum Cytokine 19 2002 228 235
40. SAS Institute Inc SAS/STAT Software: changes and enhancements through release 6.11 4th ed. 1996 SAS Institute Cary, NC
41. J. Fleiss Statistical methods for rates and proportions 1981 Wiley New York